US Broker Ratings

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating Biotech’s Growth Frontier

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has established itself as a noteworthy player in the biotechnology sector, with a specific focus on developing therapies for rare diseases..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Exploring a 76% Potential Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector might want to pay close attention to Lantheus Holdings, Inc. (NASDAQ: LNTH). With a robust portfolio of..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 32% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of genetic medicines. Headquartered..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Healthcare Game Changer with a 5.93% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. As a leader in the medical devices..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 44% Potential Upside Amidst Market Volatility

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its intriguing financial metrics...

Waystar Holding Corp. (WAY) Stock Analysis: A 41.57% Potential Upside and Strong Buy Ratings Propel Healthcare IT Specialist

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare IT sector, having carved out a niche with its innovative cloud-based payment solutions. With a..

HealthEquity, Inc. (HQY) Stock Analysis: Promising 34% Upside Potential Sparks Investor Interest

In the dynamic landscape of healthcare services, HealthEquity, Inc. (NASDAQ: HQY) emerges as a compelling investment opportunity, particularly for those eyeing robust growth potential. As a..

Verona Pharma plc (VRNA) Stock Analysis: Exploring the 0.99% Potential Upside in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical powerhouse, has become a focal point of interest in the healthcare sector, particularly within the biotechnology industry. With..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 50% Upside Potential for Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is currently making waves in the investment community with its robust pipeline of innovative..

Telix Pharmaceuticals Limited (TLX): Investor Outlook and Potential 73.33% Upside

Telix Pharmaceuticals Limited (TLX), a dynamic player in the biotechnology sector, is making waves with its innovative approach to therapeutic and diagnostic radiopharmaceuticals. With a market..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Biotech Innovator Poised for 30% Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a standout in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of transformative medicines targeting genetic..

Glaukos Corporation (GKOS) Investor Outlook: A 42.85% Upside Amidst Promising Growth in Medical Devices

Glaukos Corporation (NYSE: GKOS), a pioneering player in the healthcare sector, is captivating investor interest with its robust growth prospects and a substantial potential upside of..

Bausch + Lomb (BLCO) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector with a rich history dating back to 1853, presents a compelling investment case for..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 10.28% Upside in the Healthcare Information Sector

Doximity, Inc. (NYSE: DOCS) stands as a prominent player within the healthcare information services industry, offering a specialized digital platform that caters to medical professionals across..

Prestige Consumer Healthcare (PBH) Stock Analysis: 18.92% Potential Upside Amid Solid Performance

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is garnering attention from investors due to its robust performance and significant growth potential...

DaVita Inc. (DVA) Stock Analysis: Navigating a 15.9% Upside Amidst a Shifting Healthcare Landscape

DaVita Inc. (NYSE: DVA) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.47..

The Ensign Group, Inc. (ENSG) Stock Analysis: Unveiling a 12.9% Potential Upside for Healthcare Investors

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, operates within the medical care facilities industry in the United States. With a..

Elanco Animal Health (ELAN) Stock Analysis: Potential 16% Upside Amid Strong Analyst Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a Robust Revenue Growth of 42.20%

Oscar Health, Inc. (OSCR), a key player in the healthcare plans industry, is drawing attention from investors with its impressive revenue growth of 42.20%, despite the..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (BMRN), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising upside potential. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds